Literature DB >> 16493329

[Neurofibromatosis type 1: psychiatric disorders and quality of life impairment].

Raoul Belzeaux1, Christophe Lançon.   

Abstract

Neurofibromatosis type 1 (NF1) is often associated with psychiatric disorders, which are more frequent in NF1 than in general population (33% of patients). Dysthymia is the most frequent diagnosis (21% of patients). There is also a high prevalence of depressive mood (7%), anxiety (1-6%), and personality (3%) disorders. The risk of suicide is four times greater than in the general population. Bipolar mood disorders or schizophrenia appear to be rare. The impaired quality of life associated with NF1 may play an important role in the development of psychiatric disorders. Quality of life assessments may help to identify a population at high risk.

Entities:  

Mesh:

Year:  2006        PMID: 16493329     DOI: 10.1016/s0755-4982(06)74570-5

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  6 in total

1.  Young adults' experience of living with neurofibromatosis type 1.

Authors:  Grete Hummelvoll; Kjell Magnus Antonsen
Journal:  J Genet Couns       Date:  2012-07-20       Impact factor: 2.537

2.  Tourette's Syndrome, OCD and ADHD as a Triad in Neurofibromatosis Type 1: A Case Report.

Authors:  Apinderjit Kaur; Mahadev Singh Sen; Ragul Ganesh; Bichitra Nanda Patra; Rajesh Sagar
Journal:  Indian J Psychol Med       Date:  2022-05-08

Review 3.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

4.  Neurofibromatosis type 1 and the "elephant man's" disease: the confusion persists: an ethnographic study.

Authors:  Claire-Marie Legendre; Catherine Charpentier-Côté; Régen Drouin; Chantal Bouffard
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

5.  Assessing Psychiatric Comorbidity and Pharmacologic Treatment Patterns Among Patients With Neurofibromatosis Type 1.

Authors:  Alexander C Houpt; Shaina E Schwartz; Robert A Coover
Journal:  Cureus       Date:  2021-12-07

6.  Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.

Authors:  Marie-Laure Armand; Charles Taieb; Aline Bourgeois; Mireille Bourlier; Mohammed Bennani; Christine Bodemer; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2019-05-03       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.